Sepracor Claims Patent Priority Over Wyeth's Pristiq
Pharmaceutical rivals Sepracor Inc. and Wyeth Inc. are battling in the U.S. Patent and Trademark Office for inventorship rights to Pristiq, a Wyeth drug used to treat depression in adults....To view the full article, register now.
Already a subscriber? Click here to view full article